SpaceX Files for IPO Under Ticker SPCX Potentially Making Elon Musk a Trillionaire US Prioritizes AI Integration in Asia Following TrumpXi Meeting Senior Official Says Brookings Hutchins Center Fiscal Impact Measure Gauging Fiscal Policys Economic Influence IREN Stock Surges After 16 Billion Dell Deal to Boost AI Infrastructure Health Ministry Reclassifies CNS Drug Pregabalin to Schedule H1 to Curb Misuse Companies Double Down on Prediction Market Investments Amid Regulatory Uncertainty Trinity Biotech TRIB Q4 2024 Earnings Steep EPS Miss Weighs on Investor Sentiment NXDR Q1 2026 Earnings Narrowed Losses Signal Progress Amid Operational Efficiency ALNT Q1 2026 Earnings EPS Misses Estimates Stock Rallies 1255 CHRD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency LCID Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction CNO Q1 2026 Earnings Strong Earnings Beat Amid Modest Stock Decline Parsons Corporation PSN Gains Momentum Testing Key Resistance Levels After 367 Rally Voya Infrastructure Industrials and Materials Fund IDE Faces Selling Pressure as Shares Slide Over 1 Creative Medical Technology Holdings CELZ Slips 13 as Stock Tests Key Support at 217 DigitalOcean Plunges 6 Support Levels in Focus as Cloud Sector Headwinds Intensify Sizzle Acquisition Corp II Rights SZZLR Trading at 016 Navigating a Narrow Range Indian Benchmarks Hit Highest Close Since April on West Asia Developments Carlisle Companies Q1 2026 Earnings EPS Surpasses Estimates by 783 Kenvue Inc KVUE Holds Steady Near Support as Volume Remains Moderate InnovAge Q1 2026 Earnings Deep EPS Miss Sends Shares Lower Redwood Trust Inc 900 Senior Notes Due 2029 RWTO Q1 2026 Earnings EPS Miss Weighs on Note Performance SLM Q1 2026 Earnings EPS Surges Past Estimates Stock Gains ASPS Q1 2026 Earnings EPS Exceeds Estimates by 349 Shares Surge Equity Residential EQR Q1 2026 Earnings EPS Miss Highlights Sector Headwinds Yet Stock Edges Higher SLQT Q1 2026 Earnings Stellar Earnings Beat Overshadowed by Revenue Ambiguity Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4